Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer

Liver cancer is the third leading cause of cancer-associated mortality worldwide. By the time liver cancer is diagnosed, it is already in the advanced stage. Therefore, novel therapeutic strategies need to be identified to improve the prognosis of patients with liver cancer. In the present study, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Liyuan, Li, Shenghao, Peng, Qing, Guo, Yinglin, Ji, Jingmin, Zhang, Zhiqin, Xue, Yu, Liu, Yiwei, Shi, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299009/
https://www.ncbi.nlm.nih.gov/pubmed/34386075
http://dx.doi.org/10.3892/ol.2021.12914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299009/
https://www.ncbi.nlm.nih.gov/pubmed/34386075
http://dx.doi.org/10.3892/ol.2021.12914

Ejemplares similares